Operon HTS Oligos
Source: Operon Technologies, Inc.
Operon recently launched a revolutionary new high-throughput synthesis platform, the HTS, which has increased oligo synthesis capacity exponentially
Operon recently launched a revolutionary new high-throughput synthesis platform, the HTS, which has increased oligo synthesis capacity exponentially. Operon's HTS oligos are optimized for genomic applications, purified free of synthesis salts, and delivered ready-to-use at standard concentrations in a 96-well plate format. With the lowest list prices in the market, HTS oligos offer all high-volume genomic customers a cost-effective solution to their oligo needs.
Advantages
- Superior Quality
optimized for genomic applications, completely salt-free - High Capacity
easily scaled-up to meet the most challenging synthesis requirements - Modular Design
allows synthesis capacity to be easily allocated to specific customers or projects - Rapid Delivery
complete automation results in fast turn-around times
Operon Technologies, Inc., 1000 Atlantic Ave. Suite 108, Alameda, CA 94501. Tel: 510-865-8644; Fax: 510-865-5255.
This website uses cookies to ensure you get the best experience on our website. Learn more